Canadian breast cancer screening programs
NOTE: Currently there are five provinces (British Columbia, Alberta, Ontario, Nova Scotia, Newfoundland and Labrador) that have developed standard guidelines for MRI referral.
Breast Cancer Risk Assessment Tools
|Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA)||BOADICEA is a computer program that is used to estimate BRCA1/BRCA2 mutation carrier probabilities and breast/ovarian cancer risks on the basis of family history.|
|IBIS Breast Cancer Risk Evaluation Tool||Risk calculation program uses a woman’s family history is used to calculate the likelihood of her carrying an adverse gene, which in turn affects her likelihood of developing breast cancer.|
General Cancer Resources
|Canadian Cancer Society (CCS)||Canadian Cancer Society is a national, community-based organization of volunteers whose mission is the eradication of cancer and the enhancement of the quality of life of people living with cancer.|
|National Comprehensive Cancer Network (NCCN)||The NCCN a not-for-profit alliance of 21 of the world’s leading cancer centres, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.|
Currently, the website is attempting to meet the information needs of healthcare providers. As a result, when choosing content and terminology for the site, we have assumed that the reader has a certain amount of medical knowledge.
Healthcare providers must use their own clinical judgment in addition to the information presented herein. The authors assume no responsibility or liability resulting from the use of information on this website.
All healthcare providers using this site are encouraged to consult local genetics clinics, medical geneticists, or specialists for clarification of questions that arise relating to specific patient problems.
External links are selected and reviewed at the time a page is published. However, GEC-KO is not responsible for the content of external websites. The inclusion of a link to an external website from GEC-KO should not be understood to be an endorsement of that website or the site’s owners (or their products/services).
We strive to provide accurate, timely, unbiased and up-to-date information on this site, and make every attempt to ensure the integrity of the site. However, it is possible that the information contained here may contain inaccuracies or errors for which neither GEC-KO nor its funding agencies assume responsibility.